IsoRay, Inc. Reports Success In Brain Cancer Treatment, Shares Up Sharply

By: via Benzinga
Shares of IsoRay, Inc. (NYSE: ISR) were higher by 30 percent Tuesday morning following news of early success for its Cesium-131 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.